Biden admin allocates $5 billion for new COVID vaccines with little manufacturing guidance
Monday, July 24, 2023 | Tag Cloud | Learn about our FREE SYNDICATION Service | Sign up for our Worthy Briefs!
(Worthy News) – The Biden administration is issuing grants from a $5 billion program to expedite the next generation of COVID-19 vaccines, but pharmaceutical manufacturers are not receiving guidance about vaccine standards as the development process returns to its normally slower pace.
The initiative, known as Project NextGen, has left manufacturers confused about whether they are even eligible for funding, The New York Times reported.
For example, the Pennsylvania-based company Ocugen, which is developing an inhaled vaccine, said it was unable to receive guidance about whether it was eligible for the funding. The company said its vaccine may not have undergone enough advanced testing to qualify for the grants. [ Source (Read More…) ]
Fair Use Notice:This site contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available in our efforts to advance understanding of environmental, political, human rights, economic, democracy, scientific, and social justice issues, etc. We believe this constitutes a 'fair use' of any such copyrighted material as provided for in section 107 of the US Copyright Law. In accordance with Title 17 U.S.C. Section 107, the material on this site is distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes. For more information go to: http://www.law.cornell.edu/uscode/17/107.shtml. If you wish to use copyrighted material from this site for purposes of your own that go beyond 'fair use', you must obtain permission from the copyright owner.